No benefit of a prolonged course of corticosteroids in patients with COVID-19 secondary organizing pneumonia

B. Artignan (Nantes, France), S. Dirou (Nantes, France), M. Wargny (Nantes, France), A. Moui (Nantes, France), V. Danielo (Nantes, France), C. Defrance (Nantes, France), R. Liberge (Nantes, France), O. Morla (Nantes, France), M. Chauveau (Nantes, France), P. Le Turnier (Nantes, France), A. Asquier Khati (Nantes, France), A. Espitia Thilbault (Nantes, France), M. Artifoni (Nantes, France), M. Agbakou (Nantes, France), L. Desmedt (Nantes, France), A. Boureau (Nantes, France), E. Eschapasse (Nantes, France), F. Blanc (Nantes, France)

Source: International Congress 2022 – COVID treatments

Session: COVID treatments
Session type: Thematic Poster
Number: 2608

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Artignan (Nantes, France), S. Dirou (Nantes, France), M. Wargny (Nantes, France), A. Moui (Nantes, France), V. Danielo (Nantes, France), C. Defrance (Nantes, France), R. Liberge (Nantes, France), O. Morla (Nantes, France), M. Chauveau (Nantes, France), P. Le Turnier (Nantes, France), A. Asquier Khati (Nantes, France), A. Espitia Thilbault (Nantes, France), M. Artifoni (Nantes, France), M. Agbakou (Nantes, France), L. Desmedt (Nantes, France), A. Boureau (Nantes, France), E. Eschapasse (Nantes, France), F. Blanc (Nantes, France). No benefit of a prolonged course of corticosteroids in patients with COVID-19 secondary organizing pneumonia. 2608

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.